Whitehawk Therapeutics, Inc.
WHWK
$3.92
$0.123.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 32.60% | -70.61% | |||
| Gross Profit | -32.60% | 70.61% | |||
| SG&A Expenses | 12.79% | -12.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.33% | -64.30% | |||
| Operating Income | -27.33% | 64.30% | |||
| Income Before Tax | -31.02% | 66.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.02% | 66.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.02% | 66.27% | |||
| EBIT | -27.33% | 64.30% | |||
| EBITDA | -27.35% | 64.30% | |||
| EPS Basic | -31.01% | 66.33% | |||
| Normalized Basic EPS | -32.33% | 66.66% | |||
| EPS Diluted | -29.19% | 65.86% | |||
| Normalized Diluted EPS | -32.33% | 66.66% | |||
| Average Basic Shares Outstanding | 0.01% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||